A panel of advisors of the Food and Drug Administration on Tuesday (Oct 31) held a day-long meeting grappling with potential risks posed by a novel therapy for sickle cell disease, a rare blood disorder that affects a significant population globally.

FDA weighs risks and benefits of CRISPR therapy for sickle cell disease

As the number of hospitalizations from the virus rises in the United States, the Food and Drug Administration on Monday approved revised Covid vaccinations from Pfizer and Moderna, putting the shots on course to reach Americans within days.

US FDA approves updated Covid-19 booster shots

The US Food and Drug Administration (FDA) has granted approval for a groundbreaking vaccine, Abrysvo, for pregnant women to safeguard infants from birth up to 6 months of age against lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV), the federal health agency said in a press release.

US: FDA approves first vaccine for pregnant women to safegaurd infants from RSV

The US Food and Drug Administration (FDA) has granted accelerated approval to Pfizer's therapy for the treatment of a challenging form of blood cancer, the company announced on Monday.

Pfizer therapy for hard-to-treat blood cancer granted FDA accelerated approval 

The United States Food and Drug Administration (FDA) on Friday (August 4) approved the use of the Zurzuvae (zuranolone) pill to treat postpartum depression (PPD) in adults.

US: FDA approves first oral pill to treat postpartum depression. Check details here

The United States Food and Drug Administration (FDA), on Friday (July 28) approved the sale of a second opioid overdose reversal drug called RiVive, said the US government agency, in a statement.

US: FDA approves 'RiVive', second over-the-counter opioid overdose reversal drug

Alzheimer’s disease is often thought of as a condition that only affects the elderly. But around 3.9 million people worldwide aged 30-64 live with young-onset Alzheimer’s disease – a form of dementia in which symptoms appear before the age of 65.

Alzheimer's at age 30: The B-side of a disease that also affects young people

With its extremely high levels of caffeine, a hip new soft drink is raising fears in the United States that it might be dangerous for children, who have been snapping up the beverage since it was launched by famous YouTube personalities.

Viral caffeine-heavy drink raises concerns for US kids

United States Senate Majority Leader Chuck Schumer, on Sunday (July 9), urged the Food and Drug Administration (FDA) to investigate YouTube stars KSI and Logan Paul’s ‘PRIME’ energy drink supposedly containing nearly twice the caffeine of a Red Bull which he said is being marketed to children.

US Senator Chuck Schumer urges FDA to investigate Logan Paul, KSI’s ‘PRIME’ energy drink. Here's why

The Food and Drug Administration on Thursday fully approved the Alzheimer’s drug Leqembi, amid concerns about its safety, cost, and accessibility.

New Alzheimer’s drug Leqembi granted full FDA approval

The US Food and Drug Administration (FDA) on Thursday granted standard approval to Leqembi (lecanemab-irmb), a drug intended for the treatment of Alzheimer's disease, however, the decision also presents challenging concerns regarding the safety of the medication and its cost.

FDA grants standard approval for Alzheimer's drug, Leqembi, despite lingering concerns

The Food and Drug Administration (FDA) panel unanimously endorsed Lecanemab (Leqembi) to combat the progression of Alzheimer's. It is a breakthrough in Alzheimer's treatment.

FDA-approved drug Lecanemab becomes hope for millions of Alzheimer's patients

Health officials in Australia have issued a public warning advising men to avoid "Big Penis USA" pills after discovering they contained sildenafil — the erectile dysfunction medication sold under the brand name Viagra.

'Big Penis USA' pills banned in Australia for containing hidden drug ingredient

Following a string of deadly manufacturing mishaps, the world's biggest supplier of cheap medicine has come under heightened scrutiny. US inspectors have recently discovered extensive problems at plants controlled by some of India's largest pharmaceutical companies.

Indian pharma industry in doldrums? US FDA reports contamination in factories

US' FDA has approved Elon Musk's Neuralink for human trials. FDA earlier rejected Neuralink for human trials due to safety concerns. Will you trust Musk with your brain? Molly Gambhir reports.

Gravitas: Musk's Neuralink gets green light to conduct human trials

Elon Musk's startup Neuralink said on Thursday that it has got an approval from the US Food and Administration to test its brain implants in people. The decision comes after the company's application was rejected in early 2022, despite Musk's multiple predictions that his brain-chip business will soon receive FDA approval for human trials. The company worked through the agency's concerns over the safety of the experimental implant.

Elon Musk's Neuralink cleared for human test of brain implants

Elon Musk's bid to start human trials for Neuralink brain implants has been rejected by U.S. regulators. But Musk isn't giving up. What does he really intend to do with these chips? Molly Gambhir reports.

Gravitas: FDA rejects human trials for Neuralink implants

A US Food and Drug Administration panel on Wednesday recommended two vaccines one each by Pfizer and GSK (GlaxoSmithKline) for their use in the United States against preventing Respiratory Syncytial Virus Infection (RSV) illness.

FDA panel recommends Pfizer, GSK vaccines against RSV for older adults, what is RSV, symptoms & prevention?

As per the draft federal rules released on Wednesday, almond, soy, oat and other drinks that have been billing themselves as milk can continue using the term. The officials of the Food and Drug Administration (FDA) issued guidance which stated that plant-based beverages have not been pretending to be products from dairy animals – and that the US consumers don’t get confused by the difference.

Oat, almond drinks and soy can be billed as milk, say US regulators

Many people suffer from chronic constipation issues and it becomes painful for them to tackle it, especially if they do not wish to take any medicine. These difficulties can arise because of many reasons including bad food habits or some other clinical problem.

FDA approves a 'first-of-its-kind' vibrating pill to relieve chronic constipation

Bisexual and gay men, who are in monogamous relationships, won't be forced to abstain from sex any longer if they wish to donate blood as per the federal guidelines announced on Friday, bringing to an end a vestige of the AIDS crisis.

After years of protest, blood donation ban on gay and bisexual men eased by FDA

Leqembi, a new Alzheimer's medicine is entering the market; it is the first to have conclusive proof that it can delay the mind-robbing condition by many months.

Explained: FDA approves new Alzheimer's medicine for early-stage patients, but what are the safety concerns?

The U.S. Food and Drug Administration (FDA) is allowing retail pharmacies to offer abortion pills in the United States for the first time, the agency said on Tuesday (January 3), as more states seek to ban medication abortion.

U.S. FDA allows the sale of abortion pills at retail pharmacies

The US Food and Drug Administration (FDA) has decided to change the packaging labels for the Plan B Morning-After pill to specify that it is not an abortion pill.

Plan B is not an abortion pill, changes in packaging to clarify the same: US FDA

Fda, News on Fda, stories on Fda, articles on Fda, Fda stories at Wion, Fda news, Fda latest news

fda